ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22,615,401 | -3.2% | 2,960,131 | -9.7% | 0.30% | -10.4% |
| Q3 2022 | $23,351,000 | -18.4% | 3,279,620 | -7.3% | 0.34% | -17.3% |
| Q2 2022 | $28,631,000 | -34.4% | 3,539,055 | +12.5% | 0.40% | -20.1% |
| Q1 2022 | $43,657,000 | -21.0% | 3,145,293 | +59.8% | 0.51% | -10.9% |
| Q4 2021 | $55,234,000 | +21.6% | 1,968,431 | +47.3% | 0.57% | +23.4% |
| Q3 2021 | $45,411,000 | +15.5% | 1,336,023 | +38.8% | 0.46% | +20.1% |
| Q2 2021 | $39,322,000 | – | 962,352 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |